These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20268746)

  • 21. Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):22-3. PubMed ID: 12971510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the toxicity of some organic antimonial drugs used for the treatment of kala-azar.
    BOSE AN; GHOSH TN
    Ind Med Gaz; 1946 Jan; 81(1):13-6. PubMed ID: 21025569
    [No Abstract]   [Full Text] [Related]  

  • 23. [Kala-azar associated with congenital syphilis].
    PORTA BOSCH M
    Rev Esp Pediatr; 1955; 11(4):487-92. PubMed ID: 13290253
    [No Abstract]   [Full Text] [Related]  

  • 24. [Toxic nephritis during the course of antimony treatment of kala-azar].
    BOUDIN G; PEPIN B; MORIN
    Concours Med; 1957 Jun; 79(24):2927-9. PubMed ID: 13447377
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment for kala-azar: methods and results at the Infants' Clinic in Marseille].
    GIRAUD P; BERNARD R; ORSINI A
    Sem Hop; 1956 Jul 10-14; 32(42-43/6):2431-4. PubMed ID: 13351757
    [No Abstract]   [Full Text] [Related]  

  • 26. THE HUMAN TRYPANOSOMATIDAE. III. LEISHMANIASIS: KALA-AZAR.
    CAHILL KM
    N Y State J Med; 1963 Dec; 63():3405-9. PubMed ID: 14083434
    [No Abstract]   [Full Text] [Related]  

  • 27. Post-kala-azar dermal leishmaniasis--an unusual presentation.
    Lakhanpal S; Pandhi RK; Khaitan BK
    Acta Derm Venereol; 1998 Sep; 78(5):353-4. PubMed ID: 9779253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-kala-azar dermal leishmaniasis: a case report strikingly resembling lepromatous leprosy.
    Ramesh V; Saxena U; Misra RS; Mukherjee A
    Lepr Rev; 1991 Jun; 62(2):217-21. PubMed ID: 1651437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [ANOTHER 3 PROVEN CASES OF KALA-AZAR IN THE ZARAZA DISTRICT, STATE OF GU'ARICO, INCLUDING A FATAL CASE].
    TORREALBA JF; TORREALBA JW; RAMOS I; REQUENAOSORIO C; LEMOINE M
    Gac Med Caracas; 1963; 71():113-6. PubMed ID: 14112046
    [No Abstract]   [Full Text] [Related]  

  • 30. Post kala-azar ocular leishmaniasis.
    el Hassan AM; Khalil EA; el Sheikh EA; Zijlstra EE; Osman A; Ibrahim ME
    Trans R Soc Trop Med Hyg; 1998; 92(2):177-9. PubMed ID: 9764325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A REVIEW OF KALA-AZAR IN MALTA FROM 1947 TO 1962.
    CACHIA EA; FENECH FF
    Trans R Soc Trop Med Hyg; 1964 May; 58():234-41. PubMed ID: 14160909
    [No Abstract]   [Full Text] [Related]  

  • 32. Ketoconazole in the treatment of antimony- and pentamidine-resistant kala-azar.
    Wali JP; Aggarwal P; Gupta U; Saluja S; Singh S
    J Infect Dis; 1992 Jul; 166(1):215-6. PubMed ID: 1607703
    [No Abstract]   [Full Text] [Related]  

  • 33. Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report.
    Lindoso JAL; Moreira CHV; Celeste BJ; Oyafuso LKM; Folegatti PM; Zijlstra EE
    Rev Soc Bras Med Trop; 2018; 51(1):105-107. PubMed ID: 29513829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Autochthonous kala-azar (visceral leishmaniasis); treatment with antimonial derivatives].
    WILDE H; DI CARLO FC; PESSAT OA
    Rev Med Cordoba; 1956 Sep; 44():319-31. PubMed ID: 13420979
    [No Abstract]   [Full Text] [Related]  

  • 35. Epidemiology of visceral leishmaniasis in India.
    Bora D
    Natl Med J India; 1999; 12(2):62-8. PubMed ID: 10416321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India.
    Thakur CP; Kumar A; Mitra G; Thakur S; Sinha PK; Das P; Bhattacharya SK; Sinha A
    Indian J Med Res; 2008 Jul; 128(1):38-44. PubMed ID: 18820357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of post-kala-azar dermal leishmaniasis.
    Singh S; Sundar S
    Int J Dermatol; 1995 Sep; 34(9):668-9. PubMed ID: 7591476
    [No Abstract]   [Full Text] [Related]  

  • 38. [8 cases of kala-azar cured with glucantime].
    SALA GINABREDA JM; PI FERRER A; WOESSNER CASAS S
    Acta Pediatr Esp; 1962 Jun; 20():299-305. PubMed ID: 13991000
    [No Abstract]   [Full Text] [Related]  

  • 39. [Autochthonous kala-azar (visceral leishmaniasis); treatment with antimonial derivatives: personal observation].
    DI CARLO FC; PESSAT OA; WILDE H
    Dia Med; 1956 Nov; 28(84):2629-31; passim. PubMed ID: 13397380
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches.
    Murray HW
    Int J Infect Dis; 2000; 4(3):158-77. PubMed ID: 11179920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.